[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2574197A - Dhea combination therapy - Google Patents

Dhea combination therapy

Info

Publication number
AU2574197A
AU2574197A AU25741/97A AU2574197A AU2574197A AU 2574197 A AU2574197 A AU 2574197A AU 25741/97 A AU25741/97 A AU 25741/97A AU 2574197 A AU2574197 A AU 2574197A AU 2574197 A AU2574197 A AU 2574197A
Authority
AU
Australia
Prior art keywords
combination therapy
dhea
dhea combination
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU25741/97A
Other versions
AU734807B2 (en
Inventor
Patrick T. Prendergast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2574197A publication Critical patent/AU2574197A/en
Application granted granted Critical
Publication of AU734807B2 publication Critical patent/AU734807B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU25741/97A 1996-04-17 1997-04-17 Dhea combination therapy Ceased AU734807B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1569596P 1996-04-17 1996-04-17
US60/015695 1996-04-17
PCT/IB1997/000414 WO1997038695A1 (en) 1996-04-17 1997-04-17 Dhea combination therapy

Publications (2)

Publication Number Publication Date
AU2574197A true AU2574197A (en) 1997-11-07
AU734807B2 AU734807B2 (en) 2001-06-21

Family

ID=21773003

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25741/97A Ceased AU734807B2 (en) 1996-04-17 1997-04-17 Dhea combination therapy

Country Status (9)

Country Link
EP (1) EP0901375A1 (en)
JP (1) JP2000508654A (en)
KR (1) KR20000005539A (en)
CN (1) CN1216470A (en)
AU (1) AU734807B2 (en)
CA (1) CA2251733A1 (en)
IL (1) IL126623A0 (en)
NO (1) NO984851L (en)
WO (1) WO1997038695A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776853B2 (en) * 1998-11-24 2004-09-23 Harbor Biosciences, Inc. Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of African and American Trypanosomiasis

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
EP1133287A2 (en) * 1998-11-24 2001-09-19 Hollis-Eden Pharmaceuticals Inc. Use of 17-ketosteroids for the treatment of hepatitis c virus and other togaviruses
WO2000032176A2 (en) * 1998-11-27 2000-06-08 Hollis-Eden Pharmaceuticals, Inc. Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis
WO2014166501A2 (en) * 2013-04-10 2014-10-16 Skau Aps Use of immune suppressive peptides as adjuvants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815472A1 (en) * 1988-05-06 1989-11-16 Centre Regional De Transfusion MONOCLONAL ANTICOERPER AND ITS USE
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
HU220103B (en) * 1992-08-20 2001-10-28 Schering-Plough Corp. New application of IL-10
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776853B2 (en) * 1998-11-24 2004-09-23 Harbor Biosciences, Inc. Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of African and American Trypanosomiasis

Also Published As

Publication number Publication date
CN1216470A (en) 1999-05-12
NO984851D0 (en) 1998-10-16
EP0901375A1 (en) 1999-03-17
NO984851L (en) 1998-12-17
WO1997038695A1 (en) 1997-10-23
KR20000005539A (en) 2000-01-25
CA2251733A1 (en) 1997-10-23
JP2000508654A (en) 2000-07-11
AU734807B2 (en) 2001-06-21
IL126623A0 (en) 1999-08-17

Similar Documents

Publication Publication Date Title
AU690054B2 (en) Earmuff-eyeglass combination
AUPO203996A0 (en) Therapeutic uses
AP2002002661A0 (en) Combination therapy for oesteoporosis
AU4578297A (en) New combination
AU2784397A (en) Contrast agents
AU3645397A (en) Anticancer agents
AU3701397A (en) Anti-herpesviral agent
AUPO434196A0 (en) An improved therapeutic
AU4636396A (en) Antiglucocorticoid medicament
AU3130597A (en) Tristetraprolin
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU2574197A (en) Dhea combination therapy
AU7623898A (en) Tri-pocket
AU5330198A (en) Therapeutic compounds
AU1643797A (en) Repeater-system
AU3395795A (en) Anchorage
AU5897998A (en) 5-oxoprolinase
AUPO314896A0 (en) Therapeutic agent
AU3978697A (en) Plasmin-depletion therapy
AU1644297A (en) Improved eyewear-earplug combination
AU3389797A (en) Phosphocholinate cardenolides
AUPO860297A0 (en) Therapeutic combination
AUPO181796A0 (en) Therapeutic uses
AU2003200183A1 (en) Cholestrol-lowering Therapy
AUPO203596A0 (en) Hormone therapy

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired